| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 10/13/2004 | EP1465865A2 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 10/13/2004 | EP1465864A1 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade |
| 10/13/2004 | EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors |
| 10/13/2004 | EP1465854A2 Chalcone derivatives and their use to treat diseases |
| 10/13/2004 | EP1465488A1 Arylamines as inhibitors of chemokine binding to us28 |
| 10/13/2004 | EP1322309A4 High affinity small molecule c5a receptor modulators |
| 10/13/2004 | EP1257172B1 Fungicidal agents containing pyrrolidones as their active agents and use thereof for treating plants |
| 10/13/2004 | EP0999204B1 Novel compound having effect of promoting neuron differentiation |
| 10/13/2004 | EP0934928B1 Cyclic amine derivatives |
| 10/13/2004 | EP0736036B1 Kininogen inhibitors |
| 10/13/2004 | CN1537098A Crystalline forms VI and VII of atorvastatin calcium |
| 10/13/2004 | CN1535956A Substituted phenyl keto-enol pesticide and weedicide |
| 10/13/2004 | CN1535955A Method of preparing 2-phenyl-3-naphthyl propionic acid derivative |
| 10/13/2004 | CN1535954A Method of preparing 2-phenyl-3-naphthyl propionic acid derivative |
| 10/13/2004 | CN1170842C New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 10/13/2004 | CN1170813C N2 phenylamidine derivatives and fungicidal composition and use |
| 10/12/2004 | US6803486 Peptidomimetic; n-aminobutyl-n'-nitroguanidine derivatives |
| 10/12/2004 | US6803467 Intermediates for the production of quinolone carboxylic acid derivatives |
| 10/12/2004 | US6803455 Inhibitors of nucleoside metabolism |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/07/2004 | WO2004086050A2 Labelling agents for mass spectrometry comprising tertiary amines |
| 10/07/2004 | WO2004085391A1 Process for the synthesis of amorphous atorvastatin calcium |
| 10/07/2004 | WO2004085390A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of leuvlinic acid esters with nitro compounds |
| 10/07/2004 | WO2004085389A1 Lipid metabolism improving agent |
| 10/07/2004 | WO2004085349A2 Production of 5-methyl-1-hydrocarbyl-2-pyrrolidone by reductive amination of levulinic acid |
| 10/07/2004 | WO2004085348A2 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone |
| 10/07/2004 | WO2004085347A2 Production of n-aryl-2-lactam and n-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds |
| 10/07/2004 | WO2004085048A2 Production of 5-methyl-n-(methyl aryl)-2-pyrrolidone, 5-methyl-n-(methyl cycloalkyl)-2-pyrrolidone and 5- methyl-n-alkyl-2-pyrrolidone by reductive amination of leuvlinic acid esters with cyano compounds |
| 10/07/2004 | WO2004085047A2 Production of n-(methyl-aryl)-2-lactam, n-(methylcycloaklyl)-2-lactam and n-alkyl-2-lactam |
| 10/07/2004 | WO2004084898A1 2-phenoxy- and 2-phenylsulfomamide derivatives with ccr3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
| 10/07/2004 | WO2004084888A1 Production of 5-methyl-n-(methyl aryl)-2-pyrrolidone, 5-methyl-n-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone |
| 10/07/2004 | WO2004084887A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5- methyl-n-cycloalkyl-2-pyrrolidone by reductive amination of levulinic acid with aryl amines |
| 10/07/2004 | WO2004084840A2 Production of n-aryl-2-lactam and n-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines |
| 10/07/2004 | WO2004084633A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds |
| 10/07/2004 | WO2004047738A3 Arylcyclopropylcarboxylic amides as potassium channel openers |
| 10/07/2004 | WO2004045518A3 Open chain prolyl urea-related modulators of androgen receptor function |
| 10/07/2004 | US20040198982 such as (4S)-1-(3-bromophenyl)-N-cyanomethyl)-4-methyl-prolinamide; for treatment of osteoporosis |
| 10/07/2004 | US20040198979 antagonists of urotensin II; (R) N-[4-Chloro-3-(1-methyl-3-pyrrolidinyloxy)-phenyl]-[3-(2-chlorophenoxy)]benzenesulfonamide for example; treating various disease including cardiovascular disorders, gastrointestinal disorders, and psychological disorders |
| 10/07/2004 | US20040198779 Antiinflammatory agents; adult respiratory distress syndrome |
| 10/07/2004 | US20040198772 Antiarthritic agents |
| 10/07/2004 | US20040198591 Polyacrylate, polyacrylamide, polyvinylpyrrolidone, polysiloxane, polybutadiene, polyisoprene, polyalkane, polystyrene, and/or polyoxazoline modified by a pyrrole-2-carboxylic acid derivative; enlargement |
| 10/07/2004 | US20040194227 Pyrrolidinyl-substituted para-phenylenediamine derivatives substituted with a cationic radical, and use of these derivatives for dyeing keratin fibres |
| 10/07/2004 | CA2520860A1 Production of n-aryl-2-lactam and n-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds |
| 10/07/2004 | CA2520448A1 Production of n-(methyl-aryl)-2-lactam,n-(methyl cycloaklyl)-2-lactam and n-alkyl-2-lactam by reductive amination of lactones with aryl and alkycyano compounds |
| 10/07/2004 | CA2520431A1 Production of 5-methyl-n-(methyl aryl)-2-pyrrolidone, 5-methyl-n-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone |
| 10/07/2004 | CA2520428A1 Production of 5-methyl-n-(methyl aryl)-2-pyrrolidone, 5-methyl-n-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with cyano compounds |
| 10/07/2004 | CA2520425A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-cycloalkyl-2-pyrrolidone by reductive amination of levulinic acid with aryl amines |
| 10/07/2004 | CA2520304A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone |
| 10/07/2004 | CA2520303A1 Production of n-aryl-2-lactam and n-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines |
| 10/07/2004 | CA2520295A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds |
| 10/07/2004 | CA2520245A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of leuvlinic acid esters with nitro compounds |
| 10/07/2004 | CA2520242A1 Production of 5-methyl-1-hydrocarbyl-2-pyrrolidone by reductive amination of levulinic acid |
| 10/07/2004 | CA2520007A1 Lipid metabolism improving agent |
| 10/06/2004 | EP1463820A1 Method of screening compounds |
| 10/06/2004 | EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function |
| 10/06/2004 | EP1463724A1 Pyrrolidone carboxamides |
| 10/06/2004 | EP1463716A1 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 10/06/2004 | EP1206484B1 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 10/06/2004 | EP1165509B1 Method of producing 3,4-dihydroprolines and 3,4-dehydropiperidines |
| 10/06/2004 | EP1101755B1 Anthranilic acid derivatives |
| 10/06/2004 | EP1085000B1 Process for producing carboxylic acid derivative and condensing agent comprising quaternary ammonium salt |
| 10/06/2004 | EP0975560A4 Chiral separations of amino acids |
| 10/06/2004 | CN1535486A Novel onium salt, electrolyte for nonaqueous cell containing novel onium salt for nonaqueous cell, and method for optimizing negative electrode using electrolyte containing onium salt |
| 10/06/2004 | CN1535139A Atorvastatin hemi-calcium form VII |
| 10/06/2004 | CN1534016A Calcium acceptor active compound |
| 10/05/2004 | US6800728 Crosslinking and immobilizing biomolecules, drugs and synthetic polymers with a thiol or amino reactive group and hydrazino or oxyamino moieties |
| 10/05/2004 | US6800097 For dyeing keratin fibers; hair dyes |
| 10/05/2004 | CA2103837C Novel method of producing 7-(substituted)-9-[(substituted glycyl)amido]-6-demethyl-6-deoxytetracyclines |
| 10/05/2004 | CA2103836C 7-(substituted)-9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines |
| 09/30/2004 | WO2004083208A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | WO2004083203A1 Compositions useful as protein kinase inhibitors |
| 09/30/2004 | WO2004083180A1 Novel crystalline forms of levetiracetam |
| 09/30/2004 | WO2004083174A2 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors |
| 09/30/2004 | WO2004083170A2 Compounds, a process for their preparation and their use as dyes and pigments |
| 09/30/2004 | WO2004058705B1 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 09/30/2004 | WO2004050084A3 Ace-inhibitors having antioxidant and nitricoxid-donor activity |
| 09/30/2004 | WO2004050022B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 09/30/2004 | WO2003072535A8 Substituted hydroxyethylamines |
| 09/30/2004 | US20040192939 Comprises supported hydrogenation catalysts |
| 09/30/2004 | US20040192938 Using metal catalyst and hydrogen gas; amination; cyclization |
| 09/30/2004 | US20040192937 Production of n-aryl-2-lactam and n-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines |
| 09/30/2004 | US20040192936 Efficient, low cost; one step; catalytic |
| 09/30/2004 | US20040192935 Production of 5-methyl-N-(methyl aryl)-2-pyrrolidone, 5-methyl-N-(methyl cycloalkyl)-2-pyrrolidone and 5-methyl-N-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with cyano compounds |
| 09/30/2004 | US20040192934 One step cyclization of oxo esters, with nitro compounds in the presence of hydrogen and reduction catalysts, to form heterocyclic amides used as detergents or dispersants |
| 09/30/2004 | US20040192933 In presence of metal catalyst; one step process |
| 09/30/2004 | US20040192932 Using metal catalysts |
| 09/30/2004 | US20040192759 Use of nefiracetam for treating neurodegeneration |
| 09/30/2004 | US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation |
| 09/30/2004 | US20040192744 Inhibition of Histone Deacetylase; antiproliferative; antitumor: cell differentiation; 3,5-Dimethyl-isoxazole-4-carboxylic acid (2-amino-4,5-dichloro-phenyl)-amide |
| 09/30/2004 | US20040192742 Antiarthritic agents; muscular dystrophy; antiinflammatory agents; glomerulonephritis; malaria; oral diseases |
| 09/30/2004 | US20040192681 N-acylsulfonamide apoptosis promoters |
| 09/30/2004 | US20040192680 Novel amides that activate soluble guanylate cyclase |
| 09/30/2004 | US20040192676 Ligands of melanocortin receptors and compositions and methods related thereto |
| 09/30/2004 | US20040192673 Obesity, non-insulin-dependent diabetes,strokes, sleep disorders; antiischemic and antiemetic agents |
| 09/30/2004 | US20040191832 Avidin derivatives and uses thereof |
| 09/30/2004 | CA2522176A1 Compositions useful as protein kinase inhibitors |
| 09/30/2004 | CA2519440A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators |
| 09/30/2004 | CA2518707A1 Compounds, a process for their preparation and their use as dyes and pigments |
| 09/29/2004 | EP1462453A1 Paraphenylenediamin derivatives comprising a substituted pyrrolidinyl group and bearing a cationic radical as well as their use for dyeing keratinic fibres |
| 09/29/2004 | EP1461317A2 Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa agonists |